Urologic Oncology: Seminars and Original Investigations
Displaying 1 - 13 of 13
Joffe, B. I., Christin, J. R., Le Coz, C., Gorroochurn, P., Pak, J. S., Laplaca, C., Reyes, H. V., DeCastro, G. J., Anderson, C. B., Abate-Shen, C., Shen, M. M., McKiernan, J. M., & Lenis, A. T. (2025). Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations. Urologic Oncology: Seminars and Original Investigations. https://doi.org/10.1016/j.urolonc.2025.05.012
Publication Date
Columbia Affiliation
Vagelos College of Physicians and Surgeons; Department of Medicine; Division of Hematology/Oncology; Department of Biostatistics; Department of Urology; Department of Molecular Pharmacology and Therapeutics; Department of Pathology and Cell Biology; Department of Systems Biology; Mailman School of Public Health; Herbert Irving Comprehensive Cancer Center; Graduate School of Arts and Sciences
View
Tavelli, J. P., Chung, R., Bai, K., Gorroochurn, P., Duong, J., & Anderson, C. B. (2025). The impact of age on BCG treatment response. Urologic Oncology: Seminars and Original Investigations. https://doi.org/10.1016/j.urolonc.2025.02.004
Publication Date
Columbia Affiliation
View
Joffe, B. I., Martina, L. P., Stillman, M., Rust, D., Gorroochurn, P., Lenis, A. T., DeCastro, G. J., McKiernan, J. M., & Anderson, C. B. (2024). Tumor characteristics in immunosuppressed and renal dysfunction populations. Urologic Oncology: Seminars and Original Investigations, 42(12), 453.e9-453.e14. https://doi.org/10.1016/j.urolonc.2024.09.011
Publication Date
Columbia Affiliation
Ingram, J. W., Chung, R., Laplaca, C., McKiernan, J. M., Lenis, A. T., & Anderson, C. B. (2024). Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations, 42(9), 290.e11-290.e16. https://doi.org/10.1016/j.urolonc.2024.04.017
Publication Date
Columbia Affiliation
Gore, J. L., Follmer, K., Reynolds, J., Nash, M., Anderson, C. B., Catto, J. W. F., Chamie, K., Daneshmand, S., Dickstein, R., Garg, T., Gilbert, S. M., Guzzo, T. J., Kamat, A. M., Kates, M. R., Lane, B. R., Lotan, Y., Mansour, A. M., Master, V. A., Montgomery, J. S., … Smith, A. B. (2024). Interruptions in bladder cancer care during the COVID-19 public health emergency. Urologic Oncology: Seminars and Original Investigations, 42(4), 116.e17-116.e21. https://doi.org/10.1016/j.urolonc.2023.11.010
Publication Date
Columbia Affiliation
Chung, R., Moran, G. W., Movassaghi, M., Pohl, D., Ingram, J., Lenis, A. T., McKiernan, J. M., Anderson, C. B., & Faiena, I. (2023). Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy. Urologic Oncology: Seminars and Original Investigations, 41(8), 356.e11-356.e18. https://doi.org/10.1016/j.urolonc.2023.04.017
Publication Date
Columbia Affiliation
Wallace, B. K., Gillespie, A. M., Moran, G. W., Smigelski, M. B., & Anderson, C. B. (2022). Heterogeneity in the pharmacological management of radiation-induced hemorrhagic cystitis. Urologic Oncology: Seminars and Original Investigations, 40(12), 540.e11-540.e17. https://doi.org/10.1016/j.urolonc.2022.09.006
Publication Date
Columbia Affiliation
Chung, R., Moran, G. W., Wang, C., McKiernan, J. M., & Anderson, C. B. (2022). Partial cystectomy: Review of a single center experience from 2004 to 2019. Urologic Oncology: Seminars and Original Investigations, 40(12), 538.e1-538.e5. https://doi.org/10.1016/j.urolonc.2022.09.003
Publication Date
Columbia Affiliation
Pohar, K. S., Patel, S., Lotan, Y., Trabulsi, E., Woods, M., Downs, T., Huang, W. C., Jones, J., Taylor, J., O’Donnell, M., Bivalacqua, T. J., DeCastro, J., Steinberg, G., Kamat, A. M., Resnick, M. J., Konety, B., Schoenberg, M., Jones, J. S., & Daneshmand, S. (2022). Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study. Urologic Oncology: Seminars and Original Investigations, 40(8), 382.e1-382.e6. https://doi.org/10.1016/j.urolonc.2022.04.012
Publication Date
Columbia Affiliation
Wallace, B. K., Miles, C. H., & Anderson, C. B. (2022). Effects of race and socioeconomic status on treatment for localized renal masses in New York City. Urologic Oncology: Seminars and Original Investigations, 40(2), 65.e19-65.e26. https://doi.org/10.1016/j.urolonc.2021.11.004
Publication Date
Columbia Affiliation
Ho, P., Moran, G. W., Wang, V., Li, G., Virk, R. K., McKiernan, J. M., & Anderson, C. B. (2022). The effect of tumor grade heterogeneity on recurrence in non-muscle invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations, 40(2), 60.e11-60.e16. https://doi.org/10.1016/j.urolonc.2021.07.003
Publication Date
Columbia Affiliation
Pak, J. S., Haas, C. R., Anderson, C. B., DeCastro, G. J., Benson, M. C., & McKiernan, J. M. (2021). Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations, 39(11), 787.e9-787.e15. https://doi.org/10.1016/j.urolonc.2021.03.025
Publication Date
Columbia Affiliation
Margolin, E. J., Pina Martina, L. A., Miles, C. H., Wenske, S., McKiernan, J. M., DeCastro, G. J., Hyams, E. S., Drake, C. G., Lim, E. A., Stein, M. N., Deutsch, I., & Anderson, C. B. (2021). Telemedicine in management of genitourinary malignancies: Patient and physician perspectives. Urologic Oncology: Seminars and Original Investigations, 39(8), 480–486. https://doi.org/10.1016/j.urolonc.2021.04.003
Publication Date
Columbia Affiliation